Global Biologics and Biosimilars Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2020-2026

Global Biologics and Biosimilars Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2020-2026

Table of Contents
1 Study Coverage
1.1 Biologics and Biosimilars Product Introduction
1.2 Market by Type
1.2.1 Global Biologics and Biosimilars Market Size Growth Rate by Type
1.2.2 Monoclonal Antibodies
1.2.3 Interferon
1.2.4 Erythropoietin
1.2.5 Insulin
1.2.6 Vaccines
1.2.7 Other
1.3 Market by Application
1.3.1 Global Biologics and Biosimilars Market Size Growth Rate by Application
1.3.2 Tumor
1.3.3 Diabetes
1.3.4 Cardiovascular
1.3.5 Hemophilia
1.3.6 Other
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Biologics and Biosimilars Market Size Estimates and Forecasts
2.1.1 Global Biologics and Biosimilars Revenue 2015-2026
2.1.2 Global Biologics and Biosimilars Sales 2015-2026
2.2 Biologics and Biosimilars Market Size by Region: 2020 Versus 2026
2.3 Biologics and Biosimilars Sales by Region (2015-2026)
2.3.1 Global Biologics and Biosimilars Sales by Region: 2015-2020
2.3.2 Global Biologics and Biosimilars Sales Forecast by Region (2021-2026)
2.3.3 Global Biologics and Biosimilars Sales Market Share by Region (2015-2026)
2.4 Biologics and Biosimilars Market Estimates and Projections by Region (2021-2026)
2.4.1 Global Biologics and Biosimilars Revenue by Region: 2015-2020
2.4.2 Global Biologics and Biosimilars Revenue Forecast by Region (2021-2026)
2.4.3 Global Biologics and Biosimilars Revenue Market Share by Region (2015-2026)
3 Global Biologics and Biosimilars by Manufacturers
3.1 Global Top Biologics and Biosimilars Manufacturers by Sales
3.1.1 Global Biologics and Biosimilars Sales by Manufacturer (2015-2020)
3.1.2 Global Biologics and Biosimilars Sales Market Share by Manufacturer (2015-2019)
3.2 Global Top Biologics and Biosimilars Manufacturers by Revenue
3.2.1 Global Biologics and Biosimilars Revenue by Manufacturer (2015-2020)
3.2.2 Global Biologics and Biosimilars Revenue Share by Manufacturer (2015-2020)
3.3 Global Biologics and Biosimilars Price by Manufacturer (2015-2020)
3.4 Competitive Landscape
3.4.1 Key Biologics and Biosimilars Manufacturers Covered: Ranking by Revenue
3.4.2 Global Biologics and Biosimilars Market Concentration Ratio (CR5 and HHI) & (2015-2020)
3.4.3 Global Biologics and Biosimilars Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.5 Global Biologics and Biosimilars Manufacturing Base Distribution, Product Type
3.5.1 Biologics and Biosimilars Manufacturers Manufacturing Base Distribution, Headquarters
3.5.2 Manufacturers Biologics and Biosimilars Product Type
3.5.3 Date of International Manufacturers Enter into Biologics and Biosimilars Market
3.6 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Company Profiles
4.1 Roche
4.1.1 Roche Corporation Information
4.1.2 Roche Description, Business Overview
4.1.3 Roche Biologics and Biosimilars Products Offered
4.1.4 Roche Biologics and Biosimilars Sales, Revenue and Gross Margin (2015-2020)
4.1.5 Roche Biologics and Biosimilars Revenue by Product
4.1.6 Roche Biologics and Biosimilars Revenue by Application
4.1.7 Roche Biologics and Biosimilars Revenue by Geographic Area
4.1.8 Roche Biologics and Biosimilars Revenue by Sales Channel
4.1.9 Roche Recent Development
4.2 Amgen
4.2.1 Amgen Corporation Information
4.2.2 Amgen Description, Business Overview
4.2.3 Amgen Biologics and Biosimilars Products Offered
4.2.4 Amgen Biologics and Biosimilars Sales, Revenue and Gross Margin (2015-2020)
4.2.5 Amgen Biologics and Biosimilars Revenue by Product
4.2.6 Amgen Biologics and Biosimilars Revenue by Application
4.2.7 Amgen Biologics and Biosimilars Revenue by Geographic Area
4.2.8 Amgen Biologics and Biosimilars Revenue by Sales Channel
4.2.9 Amgen Recent Development
4.3 AbbVie
4.3.1 AbbVie Corporation Information
4.3.2 AbbVie Description, Business Overview
4.3.3 AbbVie Biologics and Biosimilars Products Offered
4.3.4 AbbVie Biologics and Biosimilars Sales, Revenue and Gross Margin (2015-2020)
4.3.5 AbbVie Biologics and Biosimilars Revenue by Product
4.3.6 AbbVie Biologics and Biosimilars Revenue by Application
4.3.7 AbbVie Biologics and Biosimilars Revenue by Geographic Area
4.3.8 AbbVie Biologics and Biosimilars Revenue by Sales Channel
4.3.9 AbbVie Recent Development
4.4 Sanofi-Aventis
4.4.1 Sanofi-Aventis Corporation Information
4.4.2 Sanofi-Aventis Description, Business Overview
4.4.3 Sanofi-Aventis Biologics and Biosimilars Products Offered
4.4.4 Sanofi-Aventis Biologics and Biosimilars Sales, Revenue and Gross Margin (2015-2020)
4.4.5 Sanofi-Aventis Biologics and Biosimilars Revenue by Product
4.4.6 Sanofi-Aventis Biologics and Biosimilars Revenue by Application
4.4.7 Sanofi-Aventis Biologics and Biosimilars Revenue by Geographic Area
4.4.8 Sanofi-Aventis Biologics and Biosimilars Revenue by Sales Channel
4.4.9 Sanofi-Aventis Recent Development
4.5 Johnson & Johnson
4.5.1 Johnson & Johnson Corporation Information
4.5.2 Johnson & Johnson Description, Business Overview
4.5.3 Johnson & Johnson Biologics and Biosimilars Products Offered
4.5.4 Johnson & Johnson Biologics and Biosimilars Sales, Revenue and Gross Margin (2015-2020)
4.5.5 Johnson & Johnson Biologics and Biosimilars Revenue by Product
4.5.6 Johnson & Johnson Biologics and Biosimilars Revenue by Application
4.5.7 Johnson & Johnson Biologics and Biosimilars Revenue by Geographic Area
4.5.8 Johnson & Johnson Biologics and Biosimilars Revenue by Sales Channel
4.5.9 Johnson & Johnson Recent Development
4.6 Pfizer
4.6.1 Pfizer Corporation Information
4.6.2 Pfizer Description, Business Overview
4.6.3 Pfizer Biologics and Biosimilars Products Offered
4.6.4 Pfizer Biologics and Biosimilars Sales, Revenue and Gross Margin (2015-2020)
4.6.5 Pfizer Biologics and Biosimilars Revenue by Product
4.6.6 Pfizer Biologics and Biosimilars Revenue by Application
4.6.7 Pfizer Biologics and Biosimilars Revenue by Geographic Area
4.6.8 Pfizer Recent Development
4.7 Novo Nordisk
4.7.1 Novo Nordisk Corporation Information
4.7.2 Novo Nordisk Description, Business Overview
4.7.3 Novo Nordisk Biologics and Biosimilars Products Offered
4.7.4 Novo Nordisk Biologics and Biosimilars Sales, Revenue and Gross Margin (2015-2020)
4.7.5 Novo Nordisk Biologics and Biosimilars Revenue by Product
4.7.6 Novo Nordisk Biologics and Biosimilars Revenue by Application
4.7.7 Novo Nordisk Biologics and Biosimilars Revenue by Geographic Area
4.7.8 Novo Nordisk Recent Development
4.8 Eli Lilly
4.8.1 Eli Lilly Corporation Information
4.8.2 Eli Lilly Description, Business Overview
4.8.3 Eli Lilly Biologics and Biosimilars Products Offered
4.8.4 Eli Lilly Biologics and Biosimilars Sales, Revenue and Gross Margin (2015-2020)
4.8.5 Eli Lilly Biologics and Biosimilars Revenue by Product
4.8.6 Eli Lilly Biologics and Biosimilars Revenue by Application
4.8.7 Eli Lilly Biologics and Biosimilars Revenue by Geographic Area
4.8.8 Eli Lilly Recent Development
4.9 Novartis
4.9.1 Novartis Corporation Information
4.9.2 Novartis Description, Business Overview
4.9.3 Novartis Biologics and Biosimilars Products Offered
4.9.4 Novartis Biologics and Biosimilars Sales, Revenue and Gross Margin (2015-2020)
4.9.5 Novartis Biologics and Biosimilars Revenue by Product
4.9.6 Novartis Biologics and Biosimilars Revenue by Application
4.9.7 Novartis Biologics and Biosimilars Revenue by Geographic Area
4.9.8 Novartis Recent Development
4.10 Merck
4.10.1 Merck Corporation Information
4.10.2 Merck Description, Business Overview
4.10.3 Merck Biologics and Biosimilars Products Offered
4.10.4 Merck Biologics and Biosimilars Sales, Revenue and Gross Margin (2015-2020)
4.10.5 Merck Biologics and Biosimilars Revenue by Product
4.10.6 Merck Biologics and Biosimilars Revenue by Application
4.10.7 Merck Biologics and Biosimilars Revenue by Geographic Area
4.10.8 Merck Recent Development
4.11 3sbio
4.11.1 3sbio Corporation Information
4.11.2 3sbio Description, Business Overview
4.11.3 3sbio Biologics and Biosimilars Products Offered
4.11.4 3sbio Biologics and Biosimilars Sales, Revenue and Gross Margin (2015-2020)
4.11.5 3sbio Biologics and Biosimilars Revenue by Product
4.11.6 3sbio Biologics and Biosimilars Revenue by Application
4.11.7 3sbio Biologics and Biosimilars Revenue by Geographic Area
4.11.8 3sbio Recent Development
4.12 Changchun High Tech
4.12.1 Changchun High Tech Corporation Information
4.12.2 Changchun High Tech Description, Business Overview
4.12.3 Changchun High Tech Biologics and Biosimilars Products Offered
4.12.4 Changchun High Tech Biologics and Biosimilars Sales, Revenue and Gross Margin (2015-2020)
4.12.5 Changchun High Tech Biologics and Biosimilars Revenue by Product
4.12.6 Changchun High Tech Biologics and Biosimilars Revenue by Application
4.12.7 Changchun High Tech Biologics and Biosimilars Revenue by Geographic Area
4.12.8 Changchun High Tech Recent Development
4.13 CP Guojian
4.13.1 CP Guojian Corporation Information
4.13.2 CP Guojian Description, Business Overview
4.13.3 CP Guojian Biologics and Biosimilars Products Offered
4.13.4 CP Guojian Biologics and Biosimilars Sales, Revenue and Gross Margin (2015-2020)
4.13.5 CP Guojian Biologics and Biosimilars Revenue by Product
4.13.6 CP Guojian Biologics and Biosimilars Revenue by Application
4.13.7 CP Guojian Biologics and Biosimilars Revenue by Geographic Area
4.13.8 CP Guojian Recent Development
4.14 Biotech
4.14.1 Biotech Corporation Information
4.14.2 Biotech Description, Business Overview
4.14.3 Biotech Biologics and Biosimilars Products Offered
4.14.4 Biotech Biologics and Biosimilars Sales, Revenue and Gross Margin (2015-2020)
4.14.5 Biotech Biologics and Biosimilars Revenue by Product
4.14.6 Biotech Biologics and Biosimilars Revenue by Application
4.14.7 Biotech Biologics and Biosimilars Revenue by Geographic Area
4.14.8 Biotech Recent Development
4.15 Gelgen
4.15.1 Gelgen Corporation Information
4.15.2 Gelgen Description, Business Overview
4.15.3 Gelgen Biologics and Biosimilars Products Offered
4.15.4 Gelgen Biologics and Biosimilars Sales, Revenue and Gross Margin (2015-2020)
4.15.5 Gelgen Biologics and Biosimilars Revenue by Product
4.15.6 Gelgen Biologics and Biosimilars Revenue by Application
4.15.7 Gelgen Biologics and Biosimilars Revenue by Geographic Area
4.15.8 Gelgen Recent Development
4.16 Innovent
4.16.1 Innovent Corporation Information
4.16.2 Innovent Description, Business Overview
4.16.3 Innovent Biologics and Biosimilars Products Offered
4.16.4 Innovent Biologics and Biosimilars Sales, Revenue and Gross Margin (2015-2020)
4.16.5 Innovent Biologics and Biosimilars Revenue by Product
4.16.6 Innovent Biologics and Biosimilars Revenue by Application
4.16.7 Innovent Biologics and Biosimilars Revenue by Geographic Area
4.16.8 Innovent Recent Development
4.17 Dong Bao
4.17.1 Dong Bao Corporation Information
4.17.2 Dong Bao Description, Business Overview
4.17.3 Dong Bao Biologics and Biosimilars Products Offered
4.17.4 Dong Bao Biologics and Biosimilars Sales, Revenue and Gross Margin (2015-2020)
4.17.5 Dong Bao Biologics and Biosimilars Revenue by Product
4.17.6 Dong Bao Biologics and Biosimilars Revenue by Application
4.17.7 Dong Bao Biologics and Biosimilars Revenue by Geographic Area
4.17.8 Dong Bao Recent Development
4.18 Ganlee
4.18.1 Ganlee Corporation Information
4.18.2 Ganlee Description, Business Overview
4.18.3 Ganlee Biologics and Biosimilars Products Offered
4.18.4 Ganlee Biologics and Biosimilars Sales, Revenue and Gross Margin (2015-2020)
4.18.5 Ganlee Biologics and Biosimilars Revenue by Product
4.18.6 Ganlee Biologics and Biosimilars Revenue by Application
4.18.7 Ganlee Biologics and Biosimilars Revenue by Geographic Area
4.18.8 Ganlee Recent Development
5 Breakdown Data by Type
5.1 Global Biologics and Biosimilars Sales by Type (2015-2026)
5.1.1 Global Biologics and Biosimilars Sales by Type (2015-2020)
5.1.2 Global Biologics and Biosimilars Sales Forecast by Type (2021-2026)
5.1.3 Global Biologics and Biosimilars Sales Market Share by Type (2015-2026)
5.2 Global Biologics and Biosimilars Revenue Forecast by Type (2015-2026)
5.2.1 Global Biologics and Biosimilars Revenue by Type (2015-2020)
5.2.2 Global Biologics and Biosimilars Revenue Forecast by Type (2021-2026)
5.2.3 Global Biologics and Biosimilars Revenue Market Share by Type (2015-2026)
5.3 Biologics and Biosimilars Average Selling Price (ASP) by Type (2015-2026)
6 Breakdown Data by Application
6.1 Global Biologics and Biosimilars Sales by Application (2015-2026)
6.1.1 Global Biologics and Biosimilars Sales by Application (2015-2020)
6.1.2 Global Biologics and Biosimilars Sales Forecast by Application (2021-2026)
6.1.3 Global Biologics and Biosimilars Sales Market Share by Application (2015-2026)
6.2 Global Biologics and Biosimilars Revenue Forecast by Application (2015-2026)
6.2.1 Global Biologics and Biosimilars Revenue by Application (2015-2020)
6.2.2 Global Biologics and Biosimilars Revenue Forecast by Application (2021-2026)
6.2.3 Global Biologics and Biosimilars Revenue Market Share by Application (2015-2026)
6.3 Biologics and Biosimilars Average Selling Price (ASP) by Application (2015-2026)
7 North America
7.1 North America Biologics and Biosimilars Market Size YoY Growth 2015-2026
7.2 North America Biologics and Biosimilars Market Facts & Figures by Country
7.2.1 North America Biologics and Biosimilars Sales by Country (2015-2026)
7.2.2 North America Biologics and Biosimilars Revenue by Country (2015-2026)
7.3 North America Biologics and Biosimilars Sales by Type
7.4 North America Biologics and Biosimilars Sales by Application
8 Asia-Pacific
8.1 Asia-Pacific Biologics and Biosimilars Market Size YoY Growth 2015-2026
8.2 Asia-Pacific Biologics and Biosimilars Market Facts & Figures by Region
8.2.1 Asia-Pacific Biologics and Biosimilars Sales by Region (2015-2026)
8.2.2 Asia-Pacific Biologics and Biosimilars Revenue by Region (2015-2026)
8.3 Asia-Pacific Biologics and Biosimilars Sales by Type
8.4 Asia-Pacific Biologics and Biosimilars Sales by Application
9 Europe
9.1 Europe Biologics and Biosimilars Market Size YoY Growth 2015-2026
9.2 Europe Biologics and Biosimilars Market Facts & Figures by Country
9.2.1 Europe Biologics and Biosimilars Sales by Country (2015-2026)
9.2.2 Europe Biologics and Biosimilars Revenue by Country (2015-2026)
9.3 Europe Biologics and Biosimilars Sales by Type
9.4 Europe Biologics and Biosimilars Sales by Application
10 Latin America
10.1 Latin America Biologics and Biosimilars Market Size YoY Growth 2015-2026
10.2 Latin America Biologics and Biosimilars Market Facts & Figures by Country
10.2.1 Latin America Biologics and Biosimilars Sales by Country (2015-2026)
10.2.2 Latin America Biologics and Biosimilars Revenue by Country (2015-2026)
10.3 Latin America Biologics and Biosimilars Sales by Type
10.4 Latin America Biologics and Biosimilars Sales by Application
11 Middle East and Africa
11.1 Middle East and Africa Biologics and Biosimilars Market Size YoY Growth 2015-2026
11.2 Middle East and Africa Biologics and Biosimilars Market Facts & Figures by Country
11.2.1 Middle East and Africa Biologics and Biosimilars Sales by Country (2015-2026)
11.2.2 Middle East and Africa Biologics and Biosimilars Revenue by Country (2015-2026)
11.3 Middle East and Africa Biologics and Biosimilars Sales by Type
11.4 Middle East and Africa Biologics and Biosimilars Sales by Application
12 Supply Chain and Sales Channel Analysis
12.1 Biologics and Biosimilars Supply Chain Analysis
12.2 Biologics and Biosimilars Key Raw Materials and Upstream Suppliers
12.3 Biologics and Biosimilars Clients Analysis
12.4 Biologics and Biosimilars Sales Channel and Sales Model Analysis
12.4.1 Biologics and Biosimilars Distribution Channel Analysis: Indirect Sales VS Direct Sales
12.4.2 Biologics and Biosimilars Distribution Channel Analysis: Online Sales VS Offline Sales
12.4.3 Biologics and Biosimilars Distributors
13 Market Dynamics
13.1 Biologics and Biosimilars Market Drivers
13.2 Biologics and Biosimilars Market Opportunities
13.3 Biologics and Biosimilars Market Challenges
13.4 Biologics and Biosimilars Market Restraints
13.5 Porter's Five Forces Analysis
14 Research Findings and Conclusion
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer
List of Tables
Table 1. Global Biologics and Biosimilars Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 2. Major Manufacturers of Monoclonal Antibodies
Table 3. Major Manufacturers of Interferon
Table 4. Major Manufacturers of Erythropoietin
Table 5. Major Manufacturers of Insulin
Table 6. Major Manufacturers of Vaccines
Table 7. Major Manufacturers of Other
Table 8. Global Biologics and Biosimilars Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 9. Global Biologics and Biosimilars Market Size by Region (US$ Million): 2020 VS 2026
Table 10. Global Biologics and Biosimilars Sales by Region (2015-2020) & (K Units)
Table 11. Global Biologics and Biosimilars Sales Forecast by Region (2021-2026) & (K Units)
Table 12. Global Biologics and Biosimilars Revenue by Region (2015-2020) & (US$ Million)
Table 13. Global Biologics and Biosimilars Revenue Forecast by Region (2021-2026) & (US$ Million)
Table 14. Global Biologics and Biosimilars Sales by Manufacturer (2015-2020) & (K Units)
Table 15. Global Biologics and Biosimilars Sales Share by Manufacturer (2015-2020)
Table 16. Biologics and Biosimilars Revenue by Manufacturer (2015-2020) & (US$ Million)
Table 17. Biologics and Biosimilars Revenue Share by Manufacturer (2015-2020)
Table 18. Key Manufacturers Biologics and Biosimilars Price (2015-2020) & (USD/Unit)
Table 19. Ranking of Global Top Biologics and Biosimilars Manufacturers by Revenue (US$ Million) in 2019
Table 20. Global Biologics and Biosimilars Manufacturers Market Concentration Ratio (CR5 and HHI) & (2015-2020)
Table 21. Global Biologics and Biosimilars by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Biologics and Biosimilars as of 2019)
Table 22. Biologics and Biosimilars Manufacturers Manufacturing Base Distribution and Headquarters
Table 23. Manufacturers Biologics and Biosimilars Product Type
Table 24. Date of International Manufacturers Enter into Biologics and Biosimilars Market
Table 25. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 26. Roche Corporation Information
Table 27. Roche Description and Business Overview
Table 28. Roche Biologics and Biosimilars Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 29. Roche Biologics and Biosimilars Product
Table 30. Roche Biologics and Biosimilars Revenue (US$ Million) and Market Share by Product
Table 31. Roche Biologics and Biosimilars Revenue (US$ Million) and Market Share by Application
Table 32. Roche Biologics and Biosimilars Revenue (US$ Million) and Market Share by Geographic Area
Table 33. Roche Biologics and Biosimilars Revenue (US$ Million) and Market Share by Sales Channel
Table 34. Roche Recent Development
Table 35. Amgen Corporation Information
Table 36. Amgen Description and Business Overview
Table 37. Amgen Biologics and Biosimilars Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 38. Amgen Biologics and Biosimilars Product
Table 39. Amgen Biologics and Biosimilars Revenue (US$ Million) and Market Share by Product
Table 40. Amgen Biologics and Biosimilars Revenue (US$ Million) and Market Share by Application
Table 41. Amgen Biologics and Biosimilars Revenue (US$ Million) and Market Share by Geographic Area
Table 42. Amgen Biologics and Biosimilars Revenue (US$ Million) and Market Share by Sales Channel
Table 43. Amgen Recent Development
Table 44. AbbVie Corporation Information
Table 45. AbbVie Description and Business Overview
Table 46. AbbVie Biologics and Biosimilars Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 47. AbbVie Biologics and Biosimilars Product
Table 48. AbbVie Biologics and Biosimilars Revenue (US$ Million) and Market Share by Product
Table 49. AbbVie Biologics and Biosimilars Revenue (US$ Million) and Market Share by Application
Table 50. AbbVie Biologics and Biosimilars Revenue (US$ Million) and Market Share by Geographic Area
Table 51. AbbVie Biologics and Biosimilars Revenue (US$ Million) and Market Share by Sales Channel
Table 52. AbbVie Recent Development
Table 53. Sanofi-Aventis Corporation Information
Table 54. Sanofi-Aventis Description and Business Overview
Table 55. Sanofi-Aventis Biologics and Biosimilars Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 56. Sanofi-Aventis Biologics and Biosimilars Product
Table 57. Sanofi-Aventis Biologics and Biosimilars Revenue (US$ Million) and Market Share by Product
Table 58. Sanofi-Aventis Biologics and Biosimilars Revenue (US$ Million) and Market Share by Application
Table 59. Sanofi-Aventis Biologics and Biosimilars Revenue (US$ Million) and Market Share by Geographic Area
Table 60. Sanofi-Aventis Biologics and Biosimilars Revenue (US$ Million) and Market Share by Sales Channel
Table 61. Sanofi-Aventis Recent Development
Table 62. Johnson & Johnson Corporation Information
Table 63. Johnson & Johnson Description and Business Overview
Table 64. Johnson & Johnson Biologics and Biosimilars Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 65. Johnson & Johnson Biologics and Biosimilars Product
Table 66. Johnson & Johnson Biologics and Biosimilars Revenue (US$ Million) and Market Share by Product
Table 67. Johnson & Johnson Biologics and Biosimilars Revenue (US$ Million) and Market Share by Application
Table 68. Johnson & Johnson Biologics and Biosimilars Revenue (US$ Million) and Market Share by Geographic Area
Table 69. Johnson & Johnson Biologics and Biosimilars Revenue (US$ Million) and Market Share by Sales Channel
Table 70. Johnson & Johnson Recent Development
Table 71. Pfizer Corporation Information
Table 72. Pfizer Description and Business Overview
Table 73. Pfizer Biologics and Biosimilars Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 74. Pfizer Biologics and Biosimilars Product
Table 75. Pfizer Biologics and Biosimilars Revenue (US$ Million) and Market Share by Product
Table 76. Pfizer Biologics and Biosimilars Revenue (US$ Million) and Market Share by Application
Table 77. Pfizer Biologics and Biosimilars Revenue (US$ Million) and Market Share by Geographic Area
Table 78. Pfizer Recent Development
Table 79. Novo Nordisk Corporation Information
Table 80. Novo Nordisk Description and Business Overview
Table 81. Novo Nordisk Biologics and Biosimilars Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 82. Novo Nordisk Biologics and Biosimilars Product
Table 83. Novo Nordisk Biologics and Biosimilars Revenue (US$ Million) and Market Share by Product
Table 84. Novo Nordisk Biologics and Biosimilars Revenue (US$ Million) and Market Share by Application
Table 85. Novo Nordisk Biologics and Biosimilars Revenue (US$ Million) and Market Share by Geographic Area
Table 86. Novo Nordisk Recent Development
Table 87. Eli Lilly Corporation Information
Table 88. Eli Lilly Description and Business Overview
Table 89. Eli Lilly Biologics and Biosimilars Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 90. Eli Lilly Biologics and Biosimilars Product
Table 91. Eli Lilly Biologics and Biosimilars Revenue (US$ Million) and Market Share by Product
Table 92. Eli Lilly Biologics and Biosimilars Revenue (US$ Million) and Market Share by Application
Table 93. Eli Lilly Biologics and Biosimilars Revenue (US$ Million) and Market Share by Geographic Area
Table 94. Eli Lilly Recent Development
Table 95. Novartis Corporation Information
Table 96. Novartis Description and Business Overview
Table 97. Novartis Biologics and Biosimilars Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 98. Novartis Biologics and Biosimilars Product
Table 99. Novartis Biologics and Biosimilars Revenue (US$ Million) and Market Share by Product
Table 100. Novartis Biologics and Biosimilars Revenue (US$ Million) and Market Share by Application
Table 101. Novartis Biologics and Biosimilars Revenue (US$ Million) and Market Share by Geographic Area
Table 102. Novartis Recent Development
Table 103. Merck Corporation Information
Table 104. Merck Description and Business Overview
Table 105. Merck Biologics and Biosimilars Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 106. Merck Biologics and Biosimilars Product
Table 107. Merck Biologics and Biosimilars Revenue (US$ Million) and Market Share by Product
Table 108. Merck Biologics and Biosimilars Revenue (US$ Million) and Market Share by Application
Table 109. Merck Biologics and Biosimilars Revenue (US$ Million) and Market Share by Geographic Area
Table 110. Merck Recent Development
Table 111. 3sbio Corporation Information
Table 112. 3sbio Description and Business Overview
Table 113. 3sbio Biologics and Biosimilars Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 114. 3sbio Biologics and Biosimilars Product
Table 115. 3sbio Biologics and Biosimilars Revenue (US$ Million) and Market Share by Product
Table 116. 3sbio Biologics and Biosimilars Revenue (US$ Million) and Market Share by Application
Table 117. 3sbio Biologics and Biosimilars Revenue (US$ Million) and Market Share by Geographic Area
Table 118. 3sbio Recent Development
Table 119. Changchun High Tech Corporation Information
Table 120. Changchun High Tech Description and Business Overview
Table 121. Changchun High Tech Biologics and Biosimilars Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 122. Changchun High Tech Biologics and Biosimilars Product
Table 123. Changchun High Tech Biologics and Biosimilars Revenue (US$ Million) and Market Share by Product
Table 124. Changchun High Tech Biologics and Biosimilars Revenue (US$ Million) and Market Share by Application
Table 125. Changchun High Tech Biologics and Biosimilars Revenue (US$ Million) and Market Share by Geographic Area
Table 126. Changchun High Tech Recent Development
Table 127. CP Guojian Corporation Information
Table 128. CP Guojian Description and Business Overview
Table 129. CP Guojian Biologics and Biosimilars Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 130. CP Guojian Biologics and Biosimilars Product
Table 131. CP Guojian Biologics and Biosimilars Revenue (US$ Million) and Market Share by Product
Table 132. CP Guojian Biologics and Biosimilars Revenue (US$ Million) and Market Share by Application
Table 133. CP Guojian Biologics and Biosimilars Revenue (US$ Million) and Market Share by Geographic Area
Table 134. CP Guojian Recent Development
Table 135. Biotech Corporation Information
Table 136. Biotech Description and Business Overview
Table 137. Biotech Biologics and Biosimilars Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 138. Biotech Biologics and Biosimilars Product
Table 139. Biotech Biologics and Biosimilars Revenue (US$ Million) and Market Share by Product
Table 140. Biotech Biologics and Biosimilars Revenue (US$ Million) and Market Share by Application
Table 141. Biotech Biologics and Biosimilars Revenue (US$ Million) and Market Share by Geographic Area
Table 142. Biotech Recent Development
Table 143. Gelgen Corporation Information
Table 144. Gelgen Description and Business Overview
Table 145. Gelgen Biologics and Biosimilars Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 146. Gelgen Biologics and Biosimilars Product
Table 147. Gelgen Biologics and Biosimilars Revenue (US$ Million) and Market Share by Product
Table 148. Gelgen Biologics and Biosimilars Revenue (US$ Million) and Market Share by Application
Table 149. Gelgen Biologics and Biosimilars Revenue (US$ Million) and Market Share by Geographic Area
Table 150. Gelgen Recent Development
Table 151. Innovent Corporation Information
Table 152. Innovent Description and Business Overview
Table 153. Innovent Biologics and Biosimilars Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 154. Innovent Biologics and Biosimilars Product
Table 155. Innovent Biologics and Biosimilars Revenue (US$ Million) and Market Share by Product
Table 156. Innovent Biologics and Biosimilars Revenue (US$ Million) and Market Share by Application
Table 157. Innovent Biologics and Biosimilars Revenue (US$ Million) and Market Share by Geographic Area
Table 158. Innovent Recent Development
Table 159. Dong Bao Corporation Information
Table 160. Dong Bao Description and Business Overview
Table 161. Dong Bao Biologics and Biosimilars Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 162. Dong Bao Biologics and Biosimilars Product
Table 163. Dong Bao Biologics and Biosimilars Revenue (US$ Million) and Market Share by Product
Table 164. Dong Bao Biologics and Biosimilars Revenue (US$ Million) and Market Share by Application
Table 165. Dong Bao Biologics and Biosimilars Revenue (US$ Million) and Market Share by Geographic Area
Table 166. Dong Bao Recent Development
Table 167. Ganlee Corporation Information
Table 168. Ganlee Description and Business Overview
Table 169. Ganlee Biologics and Biosimilars Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 170. Ganlee Biologics and Biosimilars Product
Table 171. Ganlee Biologics and Biosimilars Revenue (US$ Million) and Market Share by Product
Table 172. Ganlee Biologics and Biosimilars Revenue (US$ Million) and Market Share by Application
Table 173. Ganlee Biologics and Biosimilars Revenue (US$ Million) and Market Share by Geographic Area
Table 174. Ganlee Recent Development
Table 175. Global Biologics and Biosimilars Sales by Type (2015-2020) & (K Units)
Table 176. Global Biologics and Biosimilars Sales Forecast by Type (2021-2026) & (K Units)
Table 177. Global Biologics and Biosimilars Revenue by Type (2015-2020) & (US$ Million)
Table 178. Global Biologics and Biosimilars Revenue Forecast by Type (2021-2026) & (US$ Million)
Table 179. Global Biologics and Biosimilars Sales by Application (2015-2020) & (K Units)
Table 180. Global Biologics and Biosimilars Sales Forecast by Application (2021-2026) & (K Units)
Table 181. Global Biologics and Biosimilars Revenue by Application (2015-2020) & (US$ Million)
Table 182. Global Biologics and Biosimilars Revenue Forecast by Application (2021-2026) & (US$ Million)
Table 183. North America Biologics and Biosimilars Sales by Country (2015-2020) & (K Units)
Table 184. North America Biologics and Biosimilars Sales by Country (2021-2026) & (K Units)
Table 185. North America Biologics and Biosimilars Revenue by Country (2015-2020) & (US$ Million)
Table 186. North America Biologics and Biosimilars Revenue by Country (2021-2026) & (US$ Million)
Table 187. North America Biologics and Biosimilars Sales by Type (2015-2020) & (K Units)
Table 188. North America Biologics and Biosimilars Sales by Application (2015-2020) & (K Units)
Table 189. Asia-Pacific Biologics and Biosimilars Sales by Region (2015-2020) & (K Units)
Table 190. Asia-Pacific Biologics and Biosimilars Sales by Region (2021-2026) & (K Units)
Table 191. Asia-Pacific Biologics and Biosimilars Revenue by Region (2015-2026) & (US$ Million)
Table 192. Asia-Pacific Biologics and Biosimilars Revenue by Region (2021-2026) & (US$ Million)
Table 193. Asia-Pacific Biologics and Biosimilars Sales by Type (2015-2020) & (K Units)
Table 194. Asia-Pacific Biologics and Biosimilars Sales by Application (2015-2020) & (K Units)
Table 195. Europe Biologics and Biosimilars Sales by Country (2015-2020) & (K Units)
Table 196. Europe Biologics and Biosimilars Sales by Country (2021-2026) & (K Units)
Table 197. Europe Biologics and Biosimilars Revenue by Country (2015-2020) & (US$ Million)
Table 198. Europe Biologics and Biosimilars Revenue by Country (2021-2026) & (US$ Million)
Table 199. Europe Biologics and Biosimilars Sales by Type (2015-2020

• Clinical Results in Diabetics To Be Boosted By Smart Artificial Beta Cells

For a long time, the cure for diabetes type 1 and type 2 has relied on agonizing insulin shots for patients or insulin infusion via mechanical pumps. Regarding this, experts have been creating artificial pancreatic beta cells with the he…

• High-speed Data Transmission And High Volume Needs Propel Fiber Optic Connectors Market

Fiber optic connectors are a substantial fragment of the global telecommunication industry. Optical fibers are joined using fiber optic connectors, which allow the light conduction between two consecutive optical fibers. An additional im…

• Extensive Use of Digital Technologies for Diagnostic Applications To Boost Global Optical Imaging Market

The global optical imaging system market is predicted to reach US$ 3 billion by 2024. It is expected to grow at a stable rate and will post a CAGR of more than 8% in the coming years. The growing market infiltration of digital …

• Foremost Trends In Global Pet Care Market

The global pet care market is foretold to improve in the forthcoming years as matched to the preceding years and will showcase better sales in various market segments. It is estimated that the global pet care market will grow at a CAGR o…

• China To Review Its Food Security Laws

China has arisen as the globe’s firmest developing economy. In addition, China brags about the biggest population pool in the world. In recent times, the one child policy in the republic was terminated. This is anticipated to upsur…

Global Biologics and Biosimilars Market Growth (Status and Outlook) 2024-2030

Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 147

According to our LPI (LP Information) latest study, the global Biologics and Biosimilars market size was valued at US$ 458090 million in 2023. With growing demand in downstream market, the Biologics and Biosimilars is forecast to a readjusted size of US$ 837640 million by 2030 with a CAGR of 9.0% during review period. The research report highlights the growth potential of the global Biologics and Biosimilars market. Biologics and Biosimilars are expected to show stable growth in the futu......

Global Biosimilar Drug Market Growth 2024-2030

Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 94

According to our LPI (LP Information) latest study, the global Biosimilar Drug market size was valued at US$ million in 2023. With growing demand in downstream market, the Biosimilar Drug is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during review period. The research report highlights the growth potential of the global Biosimilar Drug market. Biosimilar Drug are expected to show stable growth in the future market. However, product differentiation, reducing cost......

Global Biologics and Biosimilars Market 2024 by Company, Regions, Type and Application, Forecast to 2030

Published: 01-Jan-2024        Price: US 3480 Onwards        Pages: 147

According to our (Global Info Research) latest study, the global Biologics and Biosimilars market size was valued at USD 481830 million in 2023 and is forecast to a readjusted size of USD 842330 million by 2030 with a CAGR of 8.3% during review period. Biologics are very specific, highly effective medicines made in living cells, and historically this was often an animal. Biologics include hormones, cytokines, growth factors, vaccines, gene and cellular therapies, fusion proteins, insulin......

Global Biosimilars Market Research Report 2023, Forecast to 2028

Published: 27-Dec-2023        Price: US 2680 Onwards        Pages: 167

A biosimilar is a biologic medical product (also known as biologic) highly similar to another already approved biological medicine (the 'reference medicine'). Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market value (million USD) data for each segment and sub-segment. This way, clients can achieve all their goals while taking advantage of emerging opportunities. Technol......

Global Biosimilars Professional Survey Report 2023, Forecast to 2028

Published: 27-Dec-2023        Price: US 3280 Onwards        Pages: 133

A biosimilar is a biologic medical product (also known as biologic) highly similar to another already approved biological medicine (the 'reference medicine'). Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market value (million USD) data for each segment and sub-segment. This way, clients can achieve all their goals while taking advantage of emerging opportunities. Technol......

Global Biosimilars Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028

Published: 07-Dec-2023        Price: US 3380 Onwards        Pages: 106

Market Overview of Global Biosimilars market: According to our latest research, the global Biosimilars market looks promising in the next 5 years. As of 2022, the global Biosimilars market was estimated at USD 8203.97 million, and it's anticipated to reach USD 40650.01 million in 2028, with a CAGR of 30.57% during the forecast years. A biosimilar product is a biologic product that is approved based on demonstrating that it is highly similar to an FDA?approved biologic product......

Global Biologics and Biosimilars Professional Survey Report 2023, Forecast to 2028

Published: 24-Nov-2023        Price: US 3280 Onwards        Pages: 134

Biologics include a wide variety of products such as gene and cell therapies, therapeutic proteins, monoclonal antibodies, and vaccines. Biosimilars are highly similar to the reference product in terms of safety, purity and potency, but may have minor differences in clinically inactive components. Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market value (million USD) da......

Global Biologics and Biosimilars Market Research Report 2023, Forecast to 2028

Published: 24-Nov-2023        Price: US 2680 Onwards        Pages: 160

Biologics include a wide variety of products such as gene and cell therapies, therapeutic proteins, monoclonal antibodies, and vaccines. Biosimilars are highly similar to the reference product in terms of safety, purity and potency, but may have minor differences in clinically inactive components. Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market value (million USD) da......

Global Biosimilar Monoclonal Antibodies Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028

Published: 16-Nov-2023        Price: US 3380 Onwards        Pages: 103

Market Overview of Global Biosimilar Monoclonal Antibodies market: According to our latest research, the global Biosimilar Monoclonal Antibodies market looks promising in the next 5 years. As of 2022, the global Biosimilar Monoclonal Antibodies market was estimated at USD 5156.19 million, and it's anticipated to reach USD 14274.14 million in 2028, with a CAGR of 18.5% during the forecast years. This report covers a research time span from 2018 to 2028, and presents a deep and......

We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s. Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors. Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business. Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision. Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us. Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done. Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )

• Ad Hoc
• Pay - as - you - go / Bucket Subscriptions
• Fixed Cost for #of reports
• Customize / Personalize as per your needs